LGND - Ligand Pharmaceuticals Forvard P/S multiplikatori

ligand.com (LGND) kompaniyasining korporativ logotipi

Kutilayotgan P/S koeffitsiyenti Ligand Pharmaceuticals (LGND) kompaniyasining baholash dinamikasini aks ettiradi va uning so'nggi qiymati 5.20 deb qayd etilgan. Royalti to'lovlari hisobiga shakllangan barqaror likvidlik ortiqchaligi kapital xarajatlarini minimallashtiradi. Aktivlarning yuqori rentabelligi diversifikatsiyalashgan patent portfeli bilan ta'minlanadi. Shu bilan birga, Ligand Pharmaceuticals ishlab chiqarish va sinovlarni autsorsing qilishga tayanib, o'z resurslarini faqat istiqbolli molekulalarni kashf etishga yo'naltiradi.

ligand.com - LGND Prognoz narxning daromadga nisbati (davr: 04.07.2022 - 16.11.2026)

Ligand Pharmaceuticals - tahliliy kesimlar va asosiy koʻrsatkichlar (LGND)

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning fundamental baholanishi:Ligand Pharma (LGND)
Ligand Corp original mahsuloti

Ligand Pharmaceuticals (LGND) kompaniyasining P/S koeffitsiyentiga bo'lgan bozor kutuvlari, bevosita tijoratlashtirish xarajatlarini bartaraf etuvchi royalti modeli tufayli uning barqarorligiga yuqori baho berilganini aks ettiradi. 5.20 ning joriy qiymati bozor kapitalizatsiyasining prognoz qilingan daromadga nisbatini o'lchaydi, bu esa investorlarga Ligand Pharmaceuticals (LGND) P/S kutuvlari orqali aktiv haddan tashqari sotib olinganmi yoki fundamental qiymatning siklik diapazoni ichida narxlar quyi chegarasini qidirayotganini aniqlash imkonini beradi.

Muhim raqobatchilar

Forvard P/S multiplikatori HLN (Haleon PLC)|Forvard P/S multiplikatori Kenvue Corp KVUE|Verona Pharma PLC - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati jyongbio.com|Amneal Pharmaceuticals Inc (AMRX) - Narxning prognoz qilingan daromadga nisbati|Perrigo Company PLC - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati alvotech.com|Forvard P/S multiplikatori Liquidia Technologies|Narxning prognoz qilingan daromadga nisbati Galapagos Genomics (GLPG)|ANIP: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori MNKD (MannKind Corp)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Amphastar (AMPH)|PCRX: Forvard narx/daromad multiplikatori|SPRY - Forvard P/S multiplikatori|Theravance Biopharma, Inc. (TBPH) - Narxning prognoz qilingan daromadga nisbati|AQST (Aquestive Therapeutics) - Narxning prognoz qilingan daromadga nisbati|SCPH (scpharmaceuticals.com) - Forvard P/S multiplikatori|TECX: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori EPRX (Eupraxia Pharmaceuticals)|Sotuvga nisbatan forvard narx BHST|Invizyne Technologies - Forvard P/S multiplikatori|oramed.com (ORMP) - Forvard narx/daromad multiplikatori|ENTX (enterabio.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HYFT|ABVC (ABVC BioPharma, Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori cumberlandpharma.com|Narxning prognoz qilingan daromadga nisbati Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori TELO (telomirpharma.com)|RANI - Forvard narx/daromad multiplikatori|SNYR - Narxning prognoz qilingan daromadga nisbati|rallybio.com - Narxning kutilayotgan daromadga nisbati|LEXX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pulmatrix Inc|PTHL (Pheton Holdings) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aptorum Group Limited APM|Narxning prognoz qilingan daromadga nisbati Lyra Therapeutics (LYRA)|Forvard narx/daromad multiplikatori Impact BioMedical Inc IBO|Narxning prognoz qilingan daromadga nisbati tnfpharma.com TNFA|Sotuvga nisbatan forvard narx YCBD|PainReform Ltd - Forvard P/S multiplikatori|Altamira Therapeutics Ltd (CYTO) - Forvard narx/daromad multiplikatori|lipella.com (LIPO) - Narxning prognoz qilingan daromadga nisbati|OptiNose (OPTN) - Forvard P/S multiplikatori|PIRS (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|PROC: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|Forvard P/S multiplikatori Qilian International Corp (QLI)|ACELYRIN, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori tffpharma.com TFFP